Loading...
Coverage For High Cost Specialty Drugs for Rheumatoid Arthritis in Medicare Part D
OBJECTIVE: One in four Medicare beneficiaries with rheumatoid arthritis (RA) use high cost biologic disease modifying drugs (DMARDs), and spending for these drugs has risen sharply for Medicare Part D. We conducted the first systematic, national investigation of how Part D plans cover biologic DMARD...
Saved in:
| Published in: | Arthritis Rheumatol |
|---|---|
| Main Authors: | , , , , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
2015
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4464809/ https://ncbi.nlm.nih.gov/pubmed/25900105 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/art.39079 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|